New drug AZD7760 tested in healthy volunteers for safety
NCT ID NCT07612813
First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times
Summary
This early-stage study tests the safety of a new drug called AZD7760 in 18 healthy Japanese adults. Participants receive a single intravenous dose and are monitored for side effects and how the drug moves through the body. The study does not aim to treat any disease; it only gathers safety and drug-level information.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS AUREUS BLOODSTREAM INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
RECRUITINGSumida-ku, 130-0004, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.